Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

Bristol-Myers surprise: Threatened I-O drug Opdivo stands its ground in lung cancer

Bristol-Myers surprise: Threatened I-O drug Opdivo stands its ground in lung cancer

Investors may be worried about Bristol-Myers Squibb’s future in lung cancer, but in the meantime, the company’s portfolio is firing on all cylinders.

Takeda’s Alunbrig beats Pfizer’s Xalkori on PFS in ALK positive NSCLC

Takeda’s Alunbrig beats Pfizer’s Xalkori on PFS in ALK positive NSCLC

Takeda’s Alunbrig has beaten Pfizer's Xalkori on progression-free survival (PFS) in a Phase III trial testing its efficacy as a front-line treatment for ALK-positive lung cancer.

Scientists identify gene linked to most people with Parkinson's disease

Scientists identify gene linked to most people with Parkinson's disease

WASHINGTON, July 25 (Xinhua) -- American scientists found a gene, previously thought linked only to three to four percent of people with Parkinson's disease, could play an important role i...

IBM Watson Reportedly Recommended Cancer Treatments That Were 'Unsafe and Incorrect'

IBM Watson Reportedly Recommended Cancer Treatments That Were 'Unsafe and Incorrect'

Internal company documents from IBM show that medical experts working with the company’s Watson supercomputer found “multiple examples of unsafe and incorrect treatment recommendations” when usi...

FDA panel votes against approval of GSK's lung disease drug

FDA panel votes against approval of GSK's lung disease drug

WASHINGTON (Reuters) - A U.

AstraZeneca joins U.S. drug price freeze for rest of 2018

AstraZeneca joins U.S. drug price freeze for rest of 2018

LONDON (Reuters) - AstraZeneca has joined other drugmakers in freezing prices in the United States for the rest of 2018, following criticism by U.

Two-drug HIV regimen from GSK bolstered by Phase 3 data

Two-drug HIV regimen from GSK bolstered by Phase 3 data

GlaxoSmithKline on Tuesday made its case for an experimental two-drug regimen of its HIV drugs dolutegravir and lamivudine, presenting detailed data from two Phase 3 trials comparing the doublet to a ...

AbbVie's new endometriosis drug to cost $10K per year

AbbVie's new endometriosis drug to cost $10K per year

The Food and Drug Administration on Tuesday approved AbbVie's gonadotropin-releasing hormone (GnRH) antagonist elagolix, giving a green light to the first oral treatment for moderate-to-s...

Is this the breakthrough that will soon end diabetes? New implant would tackle cause of the disease

Is this the breakthrough that will soon end diabetes? New implant would tackle cause of the disease

A pouch that’s implanted under the skin has the potential to ‘cure’ diabetes, say researchers.

Adding just two-and-a-half teaspoons of sugar to your tea DAILY increases your risk of Alzheimer's by 54%, study finds

Adding just two-and-a-half teaspoons of sugar to your tea DAILY increases your risk of Alzheimer's by 54%, study finds

Adding less than three teaspoons of sugar to your tea every day increases your risk of Alzheimer's disease, new research suggests.

Cannabis may boost the immune system and fight cancer, scientists claim

Cannabis may boost the immune system and fight cancer, scientists claim

Cannabis can strengthen the immune system and fight cancer, according to research.

FDA approves tafenoquine to prevent malaria relapse

FDA approves tafenoquine to prevent malaria relapse

FDA has issued Priority Review marketing approval single-dose tafenoquine (Krintafel) for relapse prevention of Plasmodium vivax malaria in patients aged >16 years receiving appropriate ...

27 28 29 303132 33 34 35